Final Dosage Forms Development

Recent Posts

• In August revenues increased by 14%, strong growth in Latvia and Russia September 17, 2019
• JSC Olainfarm investments in subsidiary OlainMed Ltd reach EUR 300 thousand in 2019 September 6, 2019
• Announcement About Convening of the Extraordinary General Meeting of Shareholders of Joint Stock Company “Olainfarm” September 4, 2019
• Notice on additional agenda items for Extraordinary General Meeting of shareholders of Joint Stock Company Olainfarm to be held on November 1th, 2019 at 11:00 September 4, 2019
• Olainfarm Group’s financial performance in the first half reached new highs – sales were 66.4 million EUR; net profit jumps to 12.2 million EUR August 30, 2019